These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1402 related items for PubMed ID: 24103663

  • 21. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C, Bai Q, Zhao Z, Zhang J.
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [Abstract] [Full Text] [Related]

  • 22. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE, Monlezun DJ, Siegler JE, Waring ED, Dowell LN, Samai AA, George AJ, Kimbrough T, Berthaud J, Martin-Schild S.
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of a modified intravenous recombinant tissue plasminogen activator regimen in Chinese patients with acute ischemic stroke.
    Pan SM, Liu JF, Liu M, Shen S, Li HJ, Dai LH, Chen XJ.
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):690-3. PubMed ID: 23111010
    [Abstract] [Full Text] [Related]

  • 24. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ.
    Cerebrovasc Dis; 2013 Jul; 35(5):461-8. PubMed ID: 23735898
    [Abstract] [Full Text] [Related]

  • 25. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
    Hsu PJ, Chen CH, Yeh SJ, Tsai LK, Tang SC, Jeng JS.
    Cerebrovasc Dis; 2016 Jul; 42(1-2):117-21. PubMed ID: 27088493
    [Abstract] [Full Text] [Related]

  • 26. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
    Chen X, Delcourt C, Sun L, Zhou Z, Yoshimura S, You S, Malavera A, Torii-Yoshimura T, Carcel C, Arima H, Hackett ML, Robinson T, Song L, Wang X, Lindley RI, Chalmers J, Anderson CS, ENCHANTED Investigators.
    Cerebrovasc Dis; 2020 Jul; 49(4):427-436. PubMed ID: 32702699
    [Abstract] [Full Text] [Related]

  • 27. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S, Liang L, Kosinski A, Hernandez AF, Schwamm LH, Smith EE, Fonarow GC, Bhatt DL, Feng W, Peterson ED, Xian Y.
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e006031. PubMed ID: 31903770
    [Abstract] [Full Text] [Related]

  • 28. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW, Zhang XJ, Cheng LS, Li GY, Zhang LJ, Ji KX, Zhao Q, Bai Y.
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [Abstract] [Full Text] [Related]

  • 29. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013 Feb; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 30. Accuracy of Stroke Diagnosis in Telestroke-Guided Tissue Plasminogen Activator Patients.
    Agrawal K, Raman R, Ernstrom K, Claycomb RJ, Meyer DM, Hemmen TM, Modir RF, Kachhi P, Meyer BC.
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2942-2946. PubMed ID: 27599906
    [Abstract] [Full Text] [Related]

  • 31. Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.
    Cucchiara B, Kasner SE, Tanne D, Levine SR, Demchuk A, Messe SR, Sansing L, Lees KR, Lyden P, SAINT Investigators.
    Stroke; 2009 Sep; 40(9):3067-72. PubMed ID: 19608993
    [Abstract] [Full Text] [Related]

  • 32. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
    Hirano T, Sasaki M, Tomura N, Ito Y, Kobayashi S, Japan Alteplase Clinical Trial Group.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
    [Abstract] [Full Text] [Related]

  • 33. Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia.
    Al Khathaami AM, Al Bdah B, Tarawneh M, Alskaini M, Alotaibi F, Alshalan A, Almuhraj M, Aldaham D, Alotaibi N.
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104761. PubMed ID: 32173225
    [Abstract] [Full Text] [Related]

  • 34. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
    Horsch AD, Bennink E, van Seeters T, Kappelle LJ, van der Graaf Y, Mali WPTM, de Jong HWAM, Velthuis BK, Dankbaar JW, DUST Investigators.
    Cerebrovasc Dis; 2018 May; 45(1-2):26-32. PubMed ID: 29402765
    [Abstract] [Full Text] [Related]

  • 35. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
    Chen J, Zhang Z, Chen L, Feng X, Hu W, Ge W, Li X, Jin P, Shao B.
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
    [Abstract] [Full Text] [Related]

  • 36. Stroke Mimics: An Important Source of Bias in Acute Ischemic Stroke Research.
    Garg R, Rech MA, Schneck M.
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2475-2480. PubMed ID: 31256984
    [Abstract] [Full Text] [Related]

  • 37. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K, Churilov L, Weir L, Dong Q, Davis S, Yan B.
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [Abstract] [Full Text] [Related]

  • 38. Effect of post thrombolytic intracerebral hemorrhage volume on 90-day outcomes in acute ischemic stroke patients.
    Gillani SA, Ma X, Huang Y, Bains NK, Fakih R, Siddiq F, French BR, Gomez CR, Lyden PD, Qureshi AI.
    J Stroke Cerebrovasc Dis; 2024 Nov; 33(11):107962. PubMed ID: 39191317
    [Abstract] [Full Text] [Related]

  • 39. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI.
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [Abstract] [Full Text] [Related]

  • 40. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J, Shen X, Han C, Mei C, Zhou Y, Wang H, Kong Y, Jiang Y, Fang Q, Cai X.
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 71.